|
|
Volumn 46, Issue 5, 2000, Pages 591-593
|
|
Why treat chronic hepatitis B in childhood with interferon α?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
PLACEBO;
VIRUS DNA;
CHILD;
CHRONIC HEPATITIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
IMMUNOTHERAPY;
MAJOR CLINICAL STUDY;
NOTE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SEROCONVERSION;
TREATMENT OUTCOME;
VIRUS HEPATITIS;
VIRUS INFECTION;
ANTIVIRAL AGENTS;
CHILD;
HEPATITIS B, CHRONIC;
HUMANS;
INTERFERON-ALPHA;
PROGNOSIS;
SEROLOGIC TESTS;
TREATMENT OUTCOME;
|
|
EID: 0034025256
PISSN: 00175749
EISSN: None
Source Type: Journal
DOI: 10.1136/gut.46.5.591 Document Type: Note |
|
Times cited : (6)
|
|
References (15)
|
